ripekg:evaluation/RIPEA6DBDE4E81DF5F0FA |
prov:used |
ripekg:retraction-notice/25238Anti-Fracture Efficacy of Risedronic Acid in Men |
ripekg:retraction-notice/25238Anti-Fracture Efficacy of Risedronic Acid in Men |
prism:doi |
10.1007/s40261-020-00999-z |
ripekg:retraction-notice/25238Anti-Fracture Efficacy of Risedronic Acid in Men |
prism:publicationDate |
2021-01-28 |
ripekg:retraction-notice/25238Anti-Fracture Efficacy of Risedronic Acid in Men |
prism:publicationName |
Clinical Drug Investigation |
ripekg:retraction-notice/25238Anti-Fracture Efficacy of Risedronic Acid in Men |
dcterms:publisher |
ripekg:publisher/RIPEPC1F35FFD9E5268DESpringer |
ripekg:retraction-notice/25238Anti-Fracture Efficacy of Risedronic Acid in Men |
dcterms:title |
Anti-Fracture Efficacy of Risedronic Acid in Men |
ripekg:retraction-notice/25238Anti-Fracture Efficacy of Risedronic Acid in Men |
http://purl.org/spar/cito/retracts |
ripekg:work/10.2165%2F00044011-200929050-00007Anti-Fracture Efficacy of Risedronic Acid in Men. A Meta-Analysis of Randomized Controlled Trials |
ripekg:retraction-notice/25238Anti-Fracture Efficacy of Risedronic Acid in Men |
rdf:type |
http://purl.org/spar/fabio/RetractionNotice |
ripekg:retraction-notice/25238Anti-Fracture Efficacy of Risedronic Acid in Men |
rdf:type |
rdfs:Resource |
ripekg:retraction-notice/25238Anti-Fracture Efficacy of Risedronic Acid in Men |
rdf:type |
owl:Thing |
ripekg:retraction-notice/25238Anti-Fracture Efficacy of Risedronic Acid in Men |
rdf:type |
ripe:IntegrityAssessmentEvidenceIntegrity assessment evidence |
ripekg:retraction-notice/25238Anti-Fracture Efficacy of Risedronic Acid in Men |
rdf:type |
ripe:RetractionNoticeRetraction notice |
ripekg:retraction-notice/25238Anti-Fracture Efficacy of Risedronic Acid in Men |
rdf:type |
tido:Evidence |
ripekg:retraction-notice/25238Anti-Fracture Efficacy of Risedronic Acid in Men |
rdf:type |
tido:PieceOfInformation |
ripekg:retraction-notice/25238Anti-Fracture Efficacy of Risedronic Acid in Men |
owl:sameAs |
https://semopenalex.org/work/W3123019227 |
ripekg:retraction-notice/25238Anti-Fracture Efficacy of Risedronic Acid in Men |
prov:wasAttributedTo |
ripekg:source/retraction-watchRetraction Watch |
ripekg:retraction-notice/25238Anti-Fracture Efficacy of Risedronic Acid in Men |
prov:wasAttributedTo |
ripekg:source/retraction-watchRetraction Watch Database |
ripekg:retraction-notice/25238Anti-Fracture Efficacy of Risedronic Acid in Men |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA6DBDE4E81DF5F0FA |
ripekg:retraction-notice/25238Anti-Fracture Efficacy of Risedronic Acid in Men |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA6DBDE4E81DF5F0FA |
ripekg:retraction-notice/25238Anti-Fracture Efficacy of Risedronic Acid in Men |
ripe:concerns |
ripekg:work/10.2165%2F00044011-200929050-00007Anti-Fracture Efficacy of Risedronic Acid in Men. A Meta-Analysis of Randomized Controlled Trials |
ripekg:retraction-notice/25238Anti-Fracture Efficacy of Risedronic Acid in Men |
ripe:rationale |
Cites Retracted Work;Concerns/Issues About Data |
ripekg:retraction-notice/25238Anti-Fracture Efficacy of Risedronic Acid in Men |
ripe:retractionWatchRecordId |
25238 |
ripekg:retraction-notice/25238Anti-Fracture Efficacy of Risedronic Acid in Men |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA6DBDE4E81DF5F0FA-human-1-1 |
ripekg:retraction-notice/25238Anti-Fracture Efficacy of Risedronic Acid in Men |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA6DBDE4E81DF5F0FA-inspectai-1-1 |